$3.45+0.06 (+1.77%)
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
EDAP TMS S.A. in the Healthcare sector is trading at $3.45. The stock is currently 32% below its 52-week high of $5.05, remaining 18.6% above its 200-day moving average. Technical signals show neutral RSI of 46 and bullish MACD crossover, explaining why EDAP maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The ...
European equities traded in the US as American depositary receipts were higher late Tuesday morning,
European equities traded in the US as American depositary receipts kicked off the week lower late Mo
European equities traded in the US as American depositary receipts were lower late Wednesday morning
European equities traded in the US as American depositary receipts eased late Thursday morning with
European equities traded in the US as American depositary receipts were higher late Wednesday mornin